StreetInsider.com News Articles

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

EINDHOVEN, the Netherlands, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Wed, 04 Feb 2026 01:30:00 -0500

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)
Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life
The first participant was enrolled at Craig Hospital in Denver, Colorado, USA

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The FDA cleared the ARC-EX System for use in conjunction with functional task practice in clinics and take-home exercises at home to improve hand strength and sensation in adults with chronic, non-progressive neurological deficits from incomplete spinal cord injuries (C2-C8 inclusive). The system delivers programmed, transcutaneous electrical spinal cord stimulation and can be operated by rehabilitation professionals in medical centers and by patients at home.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More

ONWARD Medical receives FDA clearance for home use of spinal cord device

Mon, 17 Nov 2025 01:40:56 -0500

ONWARD Medical N.V. (Euronext: ONWD) announced it received FDA 510(k) clearance to expand the indication of its ARC-EX System for home use in treating spinal cord injuries.

The device was previously cleared only for clinical use. More